Life Sciences

Xbiome expects to commence Phase 1b trial of next-generation oral live biotherapeutic product program M201 in 2022 Adds a third clinical-stage…

Purpose-Built End-to-End Forensic Informatics Platform Goes Beyond LIMS to Organize and Integrate Forensic Data from Diverse Sources, Providing…

The company’s Consumer Health division will be the first to trial the innovative programme introduced to track, measure and reduce CO2 emissions from…

Expands US-based mammalian cell culture operations KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, held a ribbon-cutting at the company’s…

Alvotech and Oaktree Acquisition Corp. II establish financing facilities to enhance the company’s capital position and to replace any redeemed…

Asahi Kasei Medical concluded an agreement on April 14, 2022 (JST) through a U.S. subsidiary to wholly acquire Bionova Scientific, LLC, a provider of…

Matthew Ros, former EVP, Chief Strategy & Business Officer of Epizyme, joins Fore as Chief Executive Officer and Director of the Board Fore…

DrugBank announces securing $9 Million CAD in seed funding to solve the challenges associated with the world's exponentially-growing biomedical data.…

Merger transaction follows a fully funded $160 million investment in Lygos to accelerate integration and scale production to meet increasing…

– JIXING to lead development and commercialization of LNZ100 and LNZ101 in Greater China – – LENZ to receive up to $110 million in upfront and…